These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3432295)

  • 1. Cells of the nervous system in vitro; applied to the study of neurodegenerative disorders.
    De Boni U
    Prog Clin Biol Res; 1987; 253():33-43. PubMed ID: 3432295
    [No Abstract]   [Full Text] [Related]  

  • 2. Free radical induced oxidative damage to DNA: relation to brain aging and neurological disorders.
    Rao KS
    Indian J Biochem Biophys; 2009 Feb; 46(1):9-15. PubMed ID: 19374248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research update: neurogenesis in adult brain and neuropsychiatric disorders.
    Elder GA; De Gasperi R; Gama Sosa MA
    Mt Sinai J Med; 2006 Nov; 73(7):931-40. PubMed ID: 17195878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of brain disorders.
    Bloom FE; Cowey A; Faull RL; Grahame-Smith DG; Gray JA; Hökfelt T; Iversen LL; Llinas RR; Marsden CD; Purpura DP
    Nature; 1992 Jul; 358(6383):184. PubMed ID: 1630482
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aluminum neurotoxicity].
    Langauer-Lewowicka H
    Neurol Neurochir Pol; 1994; 28(2):221-6. PubMed ID: 7913990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aluminum neurotoxicity and Alzheimer's disease.
    Still CN
    J S C Med Assoc; 1994 Nov; 90(11):560-4. PubMed ID: 7853860
    [No Abstract]   [Full Text] [Related]  

  • 7. Deciphering neuropharmacology: from basic neurobiology to new drug development.
    Lee CH; Lee SK; Lee JY
    Arch Pharm Res; 2010 Oct; 33(10):1463-6. PubMed ID: 21052926
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroscience. A better view of brain disorders.
    Miller G
    Science; 2006 Sep; 313(5792):1376-9. PubMed ID: 16959984
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurogenesis and neurodegenerative diseases in human.
    Zhao B; Zhong M; Jin K
    Panminerva Med; 2008 Mar; 50(1):55-64. PubMed ID: 18427388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular organization of the central nervous system: implications for new therapeutics.
    Waxman SG
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():1-21. PubMed ID: 8380236
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of chronic brain hypoperfusion in the pathogenesis of Alzheimer's disease--facts and hypotheses].
    Zádori D; Datki Z; Penke B
    Ideggyogy Sz; 2007 Nov; 60(11-12):428-37. PubMed ID: 18198789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal replacement by intracerebral neural implants in animal models of neurodegenerative disease.
    Björklund A; Brundin P; Isacson O
    Adv Neurol; 1988; 47():455-92. PubMed ID: 3278526
    [No Abstract]   [Full Text] [Related]  

  • 13. [The resistant pathological state and the pathological system].
    Kryzhanovskiĭ GN
    Fiziol Cheloveka; 1984; 10(5):786-95. PubMed ID: 6396137
    [No Abstract]   [Full Text] [Related]  

  • 14. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders.
    Papadopoulos V; Lecanu L; Brown RC; Han Z; Yao ZX
    Neuroscience; 2006; 138(3):749-56. PubMed ID: 16338086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental aluminum encephalomyelopathy. Relationship to human neurodegenerative disease.
    Rao JK; Katsetos CD; Herman MM; Savory J
    Clin Lab Med; 1998 Dec; 18(4):687-98, viii. PubMed ID: 9891607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The toxicology of aluminum in the brain: a review.
    Yokel RA
    Neurotoxicology; 2000 Oct; 21(5):813-28. PubMed ID: 11130287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid P component induces TUNEL-positive nuclei in rat brain after intrahippocampal administration.
    Urbányi Z; Sass M; Laszy J; Takács V; Gyertyán I; Pázmány T
    Brain Res; 2007 May; 1145():221-6. PubMed ID: 17337265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive dialytic encephalopathy and the problem of aluminum neurotoxicity.
    Bugiani O; Brancaccio D; Ghetti B
    Clin Nephrol; 1985; 24 Suppl 1():S20-5. PubMed ID: 3915956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific pharmacology for the treatment of Alzheimer's disease.
    Walsh TJ
    Exp Neurol; 1993 Nov; 124(1):43-6. PubMed ID: 8282078
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypothalamic-pituitary-adrenal axis, glucocorticoids, and neurologic disease.
    Herman JP; Seroogy K
    Neurol Clin; 2006 Aug; 24(3):461-81, vi. PubMed ID: 16877118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.